ID   PASK_HUMAN              Reviewed;        1323 AA.
AC   Q96RG2; G5E9F1; Q05BE4; Q68DY3; Q6GSJ5; Q86XH6; Q99763; Q9UFR7;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   15-MAR-2017, entry version 168.
DE   RecName: Full=PAS domain-containing serine/threonine-protein kinase;
DE            Short=PAS-kinase;
DE            Short=PASKIN;
DE            Short=hPASK;
DE            EC=2.7.11.1;
GN   Name=PASK; Synonyms=KIAA0135;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION AT THR-1161
RP   AND THR-1165, MUTAGENESIS OF LYS-1028; THR-1161 AND THR-1165, AND
RP   VARIANT CYS-1266.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11459942; DOI=10.1073/pnas.161284798;
RA   Rutter J., Michnoff C.H., Harper S.M., Gardner K.H., McKnight S.L.;
RT   "PAS kinase: an evolutionarily conserved PAS domain-regulated
RT   serine/threonine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8991-8996(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   MET-694 AND CYS-1266.
RC   TISSUE=Bone marrow;
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV.
RT   The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   ILE-250.
RC   TISSUE=Eye, Lymph, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 866-1323 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9110174;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF GYS1.
RX   PubMed=16275910; DOI=10.1073/pnas.0508481102;
RA   Wilson W.A., Skurat A.V., Probst B., de Paoli-Roach A., Roach P.J.,
RA   Rutter J.;
RT   "Control of mammalian glycogen synthase by PAS kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16596-16601(2005).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF PDX1.
RX   PubMed=17052199; DOI=10.1042/BST0340791;
RA   An R., da Silva Xavier G., Hao H.X., Semplici F., Rutter J.,
RA   Rutter G.A.;
RT   "Regulation by Per-Arnt-Sim (PAS) kinase of pancreatic duodenal
RT   homeobox-1 nuclear import in pancreatic beta-cells.";
RL   Biochem. Soc. Trans. 34:791-793(2006).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF EEF1A1, AUTOPHOSPHORYLATION,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF THR-1161 AND THR-1165.
RX   PubMed=17595531; DOI=10.1159/000104169;
RA   Eckhardt K., Troger J., Reissmann J., Katschinski D.M., Wagner K.F.,
RA   Stengel P., Paasch U., Hunziker P., Borter E., Barth S., Schlafli P.,
RA   Spielmann P., Stiehl D.P., Camenisch G., Wenger R.H.;
RT   "Male germ cell expression of the PAS domain kinase PASKIN and its
RT   novel target eukaryotic translation elongation factor eEF1A1.";
RL   Cell. Physiol. Biochem. 20:227-240(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   FUNCTION.
RX   PubMed=21181396; DOI=10.1007/s00125-010-2010-7;
RA   da Silva Xavier G., Farhan H., Kim H., Caxaria S., Johnson P.,
RA   Hughes S., Bugliani M., Marselli L., Marchetti P., Birzele F., Sun G.,
RA   Scharfmann R., Rutter J., Siniakowicz K., Weir G., Parker H.,
RA   Reimann F., Gribble F.M., Rutter G.A.;
RT   "Per-arnt-sim (PAS) domain-containing protein kinase is downregulated
RT   in human islets in type 2 diabetes and regulates glucagon secretion.";
RL   Diabetologia 54:819-827(2011).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF RPS6, ENZYME REGULATION, DOMAIN PROTEIN
RP   KINASE, AUTOPHOSPHORYLATION, AND LIPID-BINDING.
RX   PubMed=21418524; DOI=10.1111/j.1742-4658.2011.08100.x;
RA   Schlafli P., Troger J., Eckhardt K., Borter E., Spielmann P.,
RA   Wenger R.H.;
RT   "Substrate preference and phosphatidylinositol monophosphate
RT   inhibition of the catalytic domain of the Per-Arnt-Sim domain kinase
RT   PASKIN.";
RL   FEBS J. 278:1757-1768(2011).
RN   [16]
RP   REVIEW ON FUNCTION.
RX   PubMed=19189049; DOI=10.1007/s00018-009-8699-0;
RA   Schlafli P., Borter E., Spielmann P., Wenger R.H.;
RT   "The PAS-domain kinase PASKIN: a new sensor in energy homeostasis.";
RL   Cell. Mol. Life Sci. 66:876-883(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582 AND SER-939, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   STRUCTURE BY NMR OF 131-237.
RX   PubMed=12377121; DOI=10.1016/S0969-2126(02)00857-2;
RA   Amezcua C.A., Harper S.M., Rutter J., Gardner K.H.;
RT   "Structure and interactions of PAS kinase N-terminal PAS domain: model
RT   for intramolecular kinase regulation.";
RL   Structure 10:1349-1361(2002).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 977-1300 IN COMPLEX WITH ADP,
RP   AUTOPHOSPHORYLATION, FUNCTION, AND MUTAGENESIS OF LYS-1028; ARG-1058;
RP   ALA-1151; TYR-1152 AND THR-1161.
RX   PubMed=20943661; DOI=10.1074/jbc.M110.157594;
RA   Kikani C.K., Antonysamy S.A., Bonanno J.B., Romero R., Zhang F.F.,
RA   Russell M., Gheyi T., Iizuka M., Emtage S., Sauder J.M., Turk B.E.,
RA   Burley S.K., Rutter J.;
RT   "Structural bases of PAS domain-regulated kinase (PASK) activation in
RT   the absence of activation loop phosphorylation.";
RL   J. Biol. Chem. 285:41034-41043(2010).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-11; ILE-250; ARG-426; ALA-512;
RP   SER-514; ARG-684; ASP-725; LYS-796; GLN-844; HIS-937; MET-1210;
RP   CYS-1266 AND SER-1301.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in energy
CC       homeostasis and protein translation. Phosphorylates EEF1A1, GYS1,
CC       PDX1 and RPS6. Probably plays a role under changing environmental
CC       conditions (oxygen, glucose, nutrition), rather than under
CC       standard conditions. Acts as a sensor involved in energy
CC       homeostasis: regulates glycogen synthase synthesis by mediating
CC       phosphorylation of GYS1, leading to GYS1 inactivation. May be
CC       involved in glucose-stimulated insulin production in pancreas and
CC       regulation of glucagon secretion by glucose in alpha cells;
CC       however such data require additional evidences. May play a role in
CC       regulation of protein translation by phosphorylating EEF1A1,
CC       leading to increase translation efficiency. May also participate
CC       to respiratory regulation. {ECO:0000269|PubMed:16275910,
CC       ECO:0000269|PubMed:17052199, ECO:0000269|PubMed:17595531,
CC       ECO:0000269|PubMed:20943661, ECO:0000269|PubMed:21181396,
CC       ECO:0000269|PubMed:21418524}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Protein kinase activity is inhibited by the
CC       first PAS domain: binding of an unidentified ligand desinhibits
CC       the protein kinase activity. May be activated by
CC       autophosphorylation on Thr-1161 and Thr-1165 (PubMed:11459942).
CC       The activating role of autophosphorylation at Thr-1161 is unclear:
CC       according to a report, autophosphorylation at Thr-1161 does not
CC       play a major role in activation (PubMed:20943661).
CC       Autophosphorylation is enhanced upon phosphatidylinositol
CC       monophosphate (phosphatidylinositol 4-phosphate) binding and
CC       inhibited upon phosphatidylinositol bi- and tri-phosphate binding.
CC       In contrast, phosphorylation of target proteins is inhibited upon
CC       all phosphatidylinositol-binding (phosphatidylinositol mono- bi-
CC       and tri-phosphate). {ECO:0000269|PubMed:11459942,
CC       ECO:0000269|PubMed:20943661, ECO:0000269|PubMed:21418524}.
CC   -!- INTERACTION:
CC       P07293:CACNA1S (xeno); NbExp=2; IntAct=EBI-1042651, EBI-8613624;
CC       P16220:CREB1; NbExp=2; IntAct=EBI-1042651, EBI-711855;
CC       P02542:DES (xeno); NbExp=2; IntAct=EBI-1042651, EBI-8614455;
CC       Q28115:GFAP (xeno); NbExp=2; IntAct=EBI-1042651, EBI-907866;
CC       P02545:LMNA; NbExp=2; IntAct=EBI-1042651, EBI-351935;
CC       Q93100:PHKB; NbExp=2; IntAct=EBI-1042651, EBI-740559;
CC       P62753:RPS6; NbExp=3; IntAct=EBI-1042651, EBI-356625;
CC       P02646:TNNI3 (xeno); NbExp=2; IntAct=EBI-1042651, EBI-8614386;
CC       P20152:Vim (xeno); NbExp=2; IntAct=EBI-1042651, EBI-299269;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17595531}.
CC       Nucleus {ECO:0000269|PubMed:17595531}. Note=Localizes in the
CC       nucleus of testis germ cells and in the midpiece of sperm tails.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96RG2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RG2-2; Sequence=VSP_009302;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96RG2-4; Sequence=VSP_045543, VSP_045544;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with slightly higher
CC       expression in brain, prostate and testis. Reduced expression was
CC       found in placenta. Present in germ cells of testis and in the
CC       midpiece of sperm tails (at protein level).
CC   -!- DOMAIN: The protein kinase domain mediates binding to
CC       phosphatidylinositol. {ECO:0000269|PubMed:21418524}.
CC   -!- PTM: Autophosphorylated on Thr-1161 and Thr-1165.
CC       Autophosphorylation is activated by phospholipids.
CC       {ECO:0000269|PubMed:11459942}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA09484.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF387103; AAK69752.1; -; mRNA.
DR   EMBL; D50925; BAA09484.2; ALT_INIT; mRNA.
DR   EMBL; CR749231; CAH18087.1; -; mRNA.
DR   EMBL; AC005237; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW71238.1; -; Genomic_DNA.
DR   EMBL; BC043495; AAH43495.1; -; mRNA.
DR   EMBL; BC050565; AAH50565.1; -; mRNA.
DR   EMBL; BC063585; AAH63585.1; -; mRNA.
DR   EMBL; U79240; AAB50198.1; -; mRNA.
DR   CCDS; CCDS2545.1; -. [Q96RG2-1]
DR   CCDS; CCDS58758.1; -. [Q96RG2-4]
DR   CCDS; CCDS58759.1; -. [Q96RG2-2]
DR   PIR; T17211; T17211.
DR   RefSeq; NP_001239048.1; NM_001252119.1. [Q96RG2-2]
DR   RefSeq; NP_001239049.1; NM_001252120.1. [Q96RG2-1]
DR   RefSeq; NP_001239051.1; NM_001252122.1.
DR   RefSeq; NP_001239053.1; NM_001252124.1. [Q96RG2-4]
DR   RefSeq; NP_055963.2; NM_015148.3. [Q96RG2-1]
DR   RefSeq; XP_011509130.1; XM_011510828.1. [Q96RG2-2]
DR   RefSeq; XP_011509131.1; XM_011510829.1. [Q96RG2-2]
DR   RefSeq; XP_011509132.1; XM_011510830.1. [Q96RG2-2]
DR   RefSeq; XP_016859124.1; XM_017003635.1. [Q96RG2-1]
DR   RefSeq; XP_016859125.1; XM_017003636.1. [Q96RG2-1]
DR   UniGene; Hs.397891; -.
DR   PDB; 1LL8; NMR; -; A=131-237.
DR   PDB; 3DLS; X-ray; 2.30 A; A/B/C/D/E/F=977-1300.
DR   PDBsum; 1LL8; -.
DR   PDBsum; 3DLS; -.
DR   ProteinModelPortal; Q96RG2; -.
DR   SMR; Q96RG2; -.
DR   BioGrid; 116790; 58.
DR   IntAct; Q96RG2; 58.
DR   STRING; 9606.ENSP00000234040; -.
DR   BindingDB; Q96RG2; -.
DR   ChEMBL; CHEMBL6054; -.
DR   GuidetoPHARMACOLOGY; 2139; -.
DR   iPTMnet; Q96RG2; -.
DR   PhosphoSitePlus; Q96RG2; -.
DR   BioMuta; PASK; -.
DR   DMDM; 116242701; -.
DR   EPD; Q96RG2; -.
DR   MaxQB; Q96RG2; -.
DR   PaxDb; Q96RG2; -.
DR   PeptideAtlas; Q96RG2; -.
DR   PRIDE; Q96RG2; -.
DR   DNASU; 23178; -.
DR   Ensembl; ENST00000234040; ENSP00000234040; ENSG00000115687. [Q96RG2-1]
DR   Ensembl; ENST00000358649; ENSP00000351475; ENSG00000115687. [Q96RG2-2]
DR   Ensembl; ENST00000403638; ENSP00000384438; ENSG00000115687. [Q96RG2-4]
DR   Ensembl; ENST00000405260; ENSP00000384016; ENSG00000115687. [Q96RG2-1]
DR   Ensembl; ENST00000544142; ENSP00000441374; ENSG00000115687. [Q96RG2-1]
DR   GeneID; 23178; -.
DR   KEGG; hsa:23178; -.
DR   UCSC; uc002wao.2; human. [Q96RG2-1]
DR   CTD; 23178; -.
DR   DisGeNET; 23178; -.
DR   GeneCards; PASK; -.
DR   HGNC; HGNC:17270; PASK.
DR   HPA; HPA016450; -.
DR   HPA; HPA021079; -.
DR   MIM; 607505; gene.
DR   neXtProt; NX_Q96RG2; -.
DR   OpenTargets; ENSG00000115687; -.
DR   PharmGKB; PA32953; -.
DR   eggNOG; KOG1152; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119045; -.
DR   HOGENOM; HOG000115456; -.
DR   HOVERGEN; HBG047936; -.
DR   InParanoid; Q96RG2; -.
DR   KO; K08801; -.
DR   OMA; VANDKAC; -.
DR   OrthoDB; EOG091G07RY; -.
DR   PhylomeDB; Q96RG2; -.
DR   TreeFam; TF323242; -.
DR   SignaLink; Q96RG2; -.
DR   SIGNOR; Q96RG2; -.
DR   EvolutionaryTrace; Q96RG2; -.
DR   GeneWiki; PASK; -.
DR   GenomeRNAi; 23178; -.
DR   PRO; PR:Q96RG2; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115687; -.
DR   CleanEx; HS_PASK; -.
DR   ExpressionAtlas; Q96RG2; baseline and differential.
DR   Genevisible; Q96RG2; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0045719; P:negative regulation of glycogen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045727; P:positive regulation of translation; TAS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0070092; P:regulation of glucagon secretion; ISS:UniProtKB.
DR   GO; GO:0043576; P:regulation of respiratory gaseous exchange; ISS:UniProtKB.
DR   CDD; cd00130; PAS; 2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF13426; PAS_9; 3.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00091; PAS; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50112; PAS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Kinase; Lipid-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1   1323       PAS domain-containing serine/threonine-
FT                                protein kinase.
FT                                /FTId=PRO_0000086480.
FT   DOMAIN      119    190       PAS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      335    402       PAS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00140}.
FT   DOMAIN      999   1251       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND    1005   1013       ATP.
FT   NP_BIND    1082   1089       ATP.
FT   ACT_SITE   1128   1128       Proton acceptor.
FT   BINDING    1028   1028       ATP.
FT   BINDING    1146   1146       ATP.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CEE6}.
FT   MOD_RES      34     34       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8CEE6}.
FT   MOD_RES     582    582       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     939    939       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1161   1161       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11459942}.
FT   MOD_RES    1165   1165       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11459942}.
FT   VAR_SEQ    1111   1111       Q -> QVRAGQSR (in isoform 2).
FT                                {ECO:0000303|PubMed:8590280}.
FT                                /FTId=VSP_009302.
FT   VAR_SEQ    1112   1143       LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK -> VRAGQ
FT                                SRVSVNAGLGAWVRWLQRSVIHTRFSL (in isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045543.
FT   VAR_SEQ    1144   1323       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045544.
FT   VARIANT      11     11       E -> K (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040986.
FT   VARIANT     250    250       V -> I (in dbSNP:rs1470414).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_028293.
FT   VARIANT     426    426       Q -> R (in dbSNP:rs35187712).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040987.
FT   VARIANT     512    512       T -> A (in dbSNP:rs56033464).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040988.
FT   VARIANT     514    514       L -> S (in dbSNP:rs2240543).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_028294.
FT   VARIANT     684    684       P -> R (in dbSNP:rs56372985).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040989.
FT   VARIANT     694    694       V -> M (in dbSNP:rs6727226).
FT                                {ECO:0000269|PubMed:8590280}.
FT                                /FTId=VAR_028295.
FT   VARIANT     725    725       G -> D (in dbSNP:rs2005771).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_028296.
FT   VARIANT     796    796       E -> K (in dbSNP:rs35129131).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040990.
FT   VARIANT     844    844       P -> Q (in dbSNP:rs36082918).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040991.
FT   VARIANT     937    937       R -> H (in dbSNP:rs56139954).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040992.
FT   VARIANT    1210   1210       V -> M (in dbSNP:rs10167000).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_028297.
FT   VARIANT    1266   1266       F -> C (in dbSNP:rs1131293).
FT                                {ECO:0000269|PubMed:11459942,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:8590280}.
FT                                /FTId=VAR_028298.
FT   VARIANT    1301   1301       P -> S. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040993.
FT   MUTAGEN    1028   1028       K->R: Loss of autophosphorylating
FT                                activity. {ECO:0000269|PubMed:11459942,
FT                                ECO:0000269|PubMed:20943661}.
FT   MUTAGEN    1058   1058       R->A: Induces lower protein kinase
FT                                activity. {ECO:0000269|PubMed:20943661}.
FT   MUTAGEN    1058   1058       R->K: Does not affect protein kinase
FT                                activity. {ECO:0000269|PubMed:20943661}.
FT   MUTAGEN    1151   1151       A->K: Induces lower protein kinase
FT                                activity and ability to
FT                                autophosphorylate.
FT                                {ECO:0000269|PubMed:20943661}.
FT   MUTAGEN    1152   1152       Y->F: Induces lower protein kinase
FT                                activity. {ECO:0000269|PubMed:20943661}.
FT   MUTAGEN    1161   1161       T->A: Loss of catalytic activity
FT                                (PubMed:11459942). According to another
FT                                report, does not affect the protein
FT                                kinase activity (PubMed:20943661). Does
FT                                not affect protein translation.
FT                                {ECO:0000269|PubMed:11459942,
FT                                ECO:0000269|PubMed:17595531,
FT                                ECO:0000269|PubMed:20943661}.
FT   MUTAGEN    1165   1165       T->A: Loss of catalytic activity. Does
FT                                not affect protein translation.
FT                                {ECO:0000269|PubMed:11459942,
FT                                ECO:0000269|PubMed:17595531}.
FT   CONFLICT    205    205       S -> T (in Ref. 2; BAA09484).
FT                                {ECO:0000305}.
FT   CONFLICT    407    407       S -> C (in Ref. 4; CAH18087).
FT                                {ECO:0000305}.
FT   CONFLICT    623    623       S -> R (in Ref. 2; BAA09484).
FT                                {ECO:0000305}.
FT   CONFLICT    741    741       W -> R (in Ref. 4; CAH18087).
FT                                {ECO:0000305}.
FT   CONFLICT    850    850       T -> M (in Ref. 2; BAA09484).
FT                                {ECO:0000305}.
FT   CONFLICT    899    899       Y -> H (in Ref. 1; AAK69752).
FT                                {ECO:0000305}.
FT   CONFLICT   1048   1048       K -> E (in Ref. 4; CAH18087).
FT                                {ECO:0000305}.
FT   CONFLICT   1062   1062       A -> S (in Ref. 7; AAH50565).
FT                                {ECO:0000305}.
FT   CONFLICT   1129   1129       I -> F (in Ref. 8; AAB50198).
FT                                {ECO:0000305}.
FT   STRAND      133    138       {ECO:0000244|PDB:1LL8}.
FT   TURN        139    141       {ECO:0000244|PDB:1LL8}.
FT   STRAND      143    147       {ECO:0000244|PDB:1LL8}.
FT   HELIX       151    155       {ECO:0000244|PDB:1LL8}.
FT   TURN        159    161       {ECO:0000244|PDB:1LL8}.
FT   HELIX       167    170       {ECO:0000244|PDB:1LL8}.
FT   TURN        174    176       {ECO:0000244|PDB:1LL8}.
FT   HELIX       177    181       {ECO:0000244|PDB:1LL8}.
FT   STRAND      188    191       {ECO:0000244|PDB:1LL8}.
FT   STRAND      198    203       {ECO:0000244|PDB:1LL8}.
FT   STRAND      211    214       {ECO:0000244|PDB:1LL8}.
FT   STRAND      221    234       {ECO:0000244|PDB:1LL8}.
FT   HELIX       987    991       {ECO:0000244|PDB:3DLS}.
FT   HELIX       994    998       {ECO:0000244|PDB:3DLS}.
FT   STRAND      999   1004       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1006   1010       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1012   1018       {ECO:0000244|PDB:3DLS}.
FT   TURN       1019   1022       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1023   1032       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1039   1043       {ECO:0000244|PDB:3DLS}.
FT   TURN       1044   1046       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1047   1050       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1051   1056       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1067   1072       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1074   1082       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1090   1095       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1102   1121       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1131   1133       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1134   1136       {ECO:0000244|PDB:3DLS}.
FT   STRAND     1142   1144       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1166   1168       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1171   1174       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1182   1198       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1206   1209       {ECO:0000244|PDB:3DLS}.
FT   TURN       1210   1212       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1222   1231       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1236   1238       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1242   1247       {ECO:0000244|PDB:3DLS}.
FT   TURN       1249   1252       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1257   1259       {ECO:0000244|PDB:3DLS}.
FT   HELIX      1262   1265       {ECO:0000244|PDB:3DLS}.
SQ   SEQUENCE   1323 AA;  142929 MW;  F8A3633CC6F6C8CD CRC64;
     MEDGGLTAFE EDQRCLSQSL PLPVSAEGPA AQTTAEPSRS FSSAHRHLSR RNGLSRLCQS
     RTALSEDRWS SYCLSSLAAQ NICTSKLHCP AAPEHTDPSE PRGSVSCCSL LRGLSSGWSS
     PLLPAPVCNP NKAIFTVDAK TTEILVANDK ACGLLGYSSQ DLIGQKLTQF FLRSDSDVVE
     ALSEEHMEAD GHAAVVFGTV VDIISRSGEK IPVSVWMKRM RQERRLCCVV VLEPVERVST
     WVAFQSDGTV TSCDSLFAHL HGYVSGEDVA GQHITDLIPS VQLPPSGQHI PKNLKIQRSV
     GRARDGTTFP LSLKLKSQPS SEEATTGEAA PVSGYRASVW VFCTISGLIT LLPDGTIHGI
     NHSFALTLFG YGKTELLGKN ITFLIPGFYS YMDLAYNSSL QLPDLASCLD VGNESGCGER
     TLDPWQGQDP AEGGQDPRIN VVLAGGHVVP RDEIRKLMES QDIFTGTQTE LIAGGQLLSC
     LSPQPAPGVD NVPEGSLPVH GEQALPKDQQ ITALGREEPV AIESPGQDLL GESRSEPVDV
     KPFASCEDSE APVPAEDGGS DAGMCGLCQK AQLERMGVSG PSGSDLWAGA AVAKPQAKGQ
     LAGGSLLMHC PCYGSEWGLW WRSQDLAPSP SGMAGLSFGT PTLDEPWLGV ENDREELQTC
     LIKEQLSQLS LAGALDVPHA ELVPTECQAV TAPVSSCDLG GRDLCGGCTG SSSACYALAT
     DLPGGLEAVE AQEVDVNSFS WNLKELFFSD QTDQTSSNCS CATSELRETP SSLAVGSDPD
     VGSLQEQGSC VLDDRELLLL TGTCVDLGQG RRFRESCVGH DPTEPLEVCL VSSEHYAASD
     RESPGHVPST LDAGPEDTCP SAEEPRLNVQ VTSTPVIVMR GAAGLQREIQ EGAYSGSCYH
     RDGLRLSIQF EVRRVELQGP TPLFCCWLVK DLLHSQRDSA ARTRLFLASL PGSTHSTAAE
     LTGPSLVEVL RARPWFEEPP KAVELEGLAA CEGEYSQKYS TMSPLGSGAF GFVWTAVDKE
     KNKEVVVKFI KKEKVLEDCW IEDPKLGKVT LEIAILSRVE HANIIKVLDI FENQGFFQLV
     MEKHGSGLDL FAFIDRHPRL DEPLASYIFR QLVSAVGYLR LKDIIHRDIK DENIVIAEDF
     TIKLIDFGSA AYLERGKLFY TFCGTIEYCA PEVLMGNPYR GPELEMWSLG VTLYTLVFEE
     NPFCELEETV EAAIHPPYLV SKELMSLVSG LLQPVPERRT TLEKLVTDPW VTQPVNLADY
     TWEEVFRVNK PESGVLSAAS LEMGNRSLSD VAQAQELCGG PVPGEAPNGQ GCLHPGDPRL
     LTS
//
